Month: August 2021

Categories
Pharmaceutical

Europe Diet Pills Market is projected to reach a value of US$ 868 Mn by 2031, Finds Fact.MR

According to a new report published by Fact.MR, a market research and competitive intelligence provider, the Europe diet pills market was valued at US$ 654 Mn in 2020, and is predicted to expand at a CAGR of around 2.6% over the forecast period (2021–2031).

Factors boosting demand for diet pills in Europe include rising incidence of type-2 diabetes, high cholesterol, and high blood pressure. Constant clinical trials for new medications will support market growth over the coming years. Moreover, growing health awareness is likewise driving developments in the market.

Currently, obesity is observed as a serious health concern, which leads to various other health problems. Diet pills are medicines used to slim down by losing weight along with exercise and an appropriate diet. With the growing trend of fitness in the young populous, there is increasing demand for these weight management products. These medicines act as a supplementary measure for weigh reduction other than routine regime of exercise and dietary patterns.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=6494

Key Takeaways from Market Study
  • Glucomannan is expected to contribute more than 41% revenue share in the market by 2031.
  • Among all the drug type, demand for herbal supplements is expected to increase at a CAGR of 3% through 2031.
  • Appetite controlling pills dominate the market among the mechanisms, and are expect to reach a valuation of US$ 595 Mn by 2031.
  • The U.K. holds the highest share in the Europe diet pills market, while Germany is the next leading country, with these markets expected to progress at 3.6% and 3% CAGRs, respectively.

“Growing prevalence of obesity, unhealthy lifestyle, and rising awareness regarding preventive health are factors that have changed the focus of the pharmaceutical industry towards the development of weight loss pills,” says an analyst of Fact.MR.

europe diet pills market drug by FactMR
Increasing Number of Manufacturers Innovating Weight Management Products

Innovation has played a consistence part in the development of dietary pills, which is creating business opportunities for manufacturers. New product development with more health benefits is encouraging consumers to try novel nutrition supplements. Key players are offering dietary pills for caloric restriction to overcome weight-related risk factors such as diabetes and hypertension.

Growing prevalence of obesity has propelled manufacturers to innovate more effective diet pill supplements. Expanding technological platforms and increased research on innovative weight management products are expected to result in increased growth of the market.

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6494

Key Takeaways for Europe Diet Pills Market Research Report:

  • Demand for prescription-based pills for weight loss will continue rising in the U.K. Fact MR predicts overall diet pill sales in the country to surpass US$ 193 Mn by 2031.
  • Sales of diet pills in Germany will rise at 3% CAGR owing to rising concerns about health and wellness.
  • By drug class, glucomannan segment accounted for over 39.5% of the Europe market in 2020.
  • By drug type, herbal diet supplements sales totalled US$ 444.3 Mn in 2020 owing to increase in demand for organic product consumption.

Growth Drivers:

  • Rising spending on dietary supplements and nutrition are driving demand for diet pills for appetite control.
  • Expansion of distribution channels for diet pills will bolster sales opportunities in Europe.
  • Rising adoption of drugs for weight loss and obesity-control will accelerate demand for weight loss pills in Europe.
  • Increasing availability across e-commerce platforms will encourage diet pill sales in Europe.

Get More Insights-https://www.biospace.com/article/herbal-supplements-make-inroads-in-europe-diet-pills-market-with-total-sales-projected-to-surpass-us-611-6-mn-by-2031-fact-mr/

Key Restraints:

  • High cost of drug development is hindering demand for diet pills.
  • Stringent regulations imposed by research and development of obesity related drugs will restrain market growth.
  • Adoption of off-label drugs limits penetration of actual drugs which is restraining market growth.

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/europe-diet-pills-market
Press Release: https://www.factmr.com/media-release/2100/europe-diet-pills-trends

Categories
Pharmaceutical

Interdental Cleaning Products Market is expected to reach a valuation of over US$ 4 Bn by 2031- Exclusive Report by Fact.MR

As per a new report published by Fact.MR – a market research and competitive intelligence provider, the global market for interdental cleaning products was valued at US$ 3 Bn in 2020, and is projected to top US$ 4 Bn by 2031, expanding at a CAGR of 3%. Offline sales hold 90% share of global revenue, and are expected to witness steady growth over the coming years.

Fact.MR anticipates significant surge in demand for interdental cleaning products attributable to factors such as growing oral health consciousness among consumers, efforts towards preventive dental care, government initiatives towards advanced oral health awareness, and investments into product research & development by leading market players.

Over the last decade, there has been an increase in dental problems such as plaque in between the teeth, increasing dental cavities, bad breath, and inflammation of the gums among the population worldwide. This has, in turn, fuelled product demand. Many innovative products such as dental floss, electric interdental toothbrushes, dental tapes, and tongue cleaners are being adopted by high- and middle-income people across countries.

Request a report sample to gain comprehensive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=6484

Government initiatives are playing a critical role in not only increasing access to interdental cleaning products, but also in boosting user awareness. Collaborations between governments and professional dental organizations are critical to reach a large number of potential users.

interdental cleaning products market by FactMR
Key Takeaways from Market Study
  • Key factors driving demand for interdental cleaning products are rise in prevalence of oral diseases worldwide and growing awareness towards maintaining dental hygiene.
  • Europe accounts for around 29% share of global revenue from interdental cleaning products, and demand in the region is expected to further surge across the forecast period.
  • Demand for interdental cleaning products in China is projected to top US$ 852Mn by 2031, increasing at a CAGR of 5%.
  • Owing to their usage feasibility, global demand for interdental brushes is anticipated to expand at a CAGR of 5% through 2031.
  • Offline sales hold 90% share of global revenue for interdental cleaning products, and are expected to witness significant growth over the coming years.

“Increasing awareness towards maintaining dental hygiene to surge demand for interdental cleaning products,” Says a Fact.MR analyst.

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6484
Sales Analysis of Interdental Cleaning Products from 2016 to 2020 Vs Demand Outlook for 2021 to 2031

As per Fact.MR – a market research and competitive intelligence provider, the global interdental cleaning products market was valued at US$ 950 Mn in 2016, and is anticipated to rise at a CAGR of 3% to top US$ 4 Bn by 2031.

Over the last decade, there has been a rise in dental problems such as plaque, dental cavities, bad breath, and inflammation of the gums across the world. This has fuelled demand for interdental cleaning products.

Increasing disposable income in developing countries such as India, China, and Japan is leading to the market growth of interdental cleaning products. Many innovative products such as dental floss, electric interdental toothbrushes, dental tapes, and tongue cleaners are being adopted by high and middle-income people.

Get More Insights-https://www.biospace.com/article/rising-cases-of-gastrointestinal-disorders-are-driving-the-nizatidine-market-fact-mr/

More Valuable Insights

Fact.MR, in its new offering, presents an unbiased analysis of the interdental cleaning products market, presenting historical market data (2016-2020) and forecast statistics for the period of 2021-2031.

The study reveals essential insights on the basis of product (interdental brushes, toothpicks, dental tapes, and dental floss) and sales channel (offline and online), across major regions of the world (North America, Europe, Asia Pacific, Central & South America, and the Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/interdental-cleaning-products-market
Press Release: https://www.factmr.com/media-release/2096/global-interdental-cleaning-products-trends

Categories
Pharmaceutical

Compound Houttuyina Market is Registering a CAGR Exceeding 10% Across the 2021-2031 Forecast Period

Fact.MR’s global compound houttuynia market report predicts a highly optimistic outlook for the 2021-2031 forecast period, estimating a CAGR exceeding 10% to reach a multi-million dollar valuation. Extensive uptake of alternative and herbal medicine is acting as the primary growth catalyst for the market.

Historically, the market expanded at a CAGR of approximately 10% from 2016 to 2020. Herbal medicine is being extensively adopted to address conditions such as respiratory disorders and other infectious ailments. Additionally, they are also proving to be effective against various forms of cancers.

According to GLOBOCAN 2020, worldwide, an estimated 19.3 million new cancer cases, 18.1 million excluding non-melanoma skin cancer, and almost 10.0 million cancer deaths excluding non-melanoma skin cancer occurred in 2020.Lung cancer remained the leading cause of cancer death, with an estimated 1.8 million deaths (18%), followed by colorectal (9.4%), liver (8.3%), stomach (7.7%), and female breast (6.9%) cancer.

Uptake of compound houttuynia products is expected to incline significantly, with manufacturers deepening penetration across key markets such as China, India, and Japan.

For more Insights into the Market, Request a Sample of this Report
https://www.factmr.com/connectus/sample?flag=S&rep_id=6324

According to Fact.MR’s analysis, the global conductive plastic compound market is expected to exceed a valuation of US$ 20.5 billion by 2031-end.

“Increasing application of conductive plastic compounds in automotive and electrical & electronics industry have prompted the manufacturers to come up with sustainable solution and strategies to improve their revenue across developed nations,” says a Fact.MR analyst. 

compound houttuynia market

Key Takeaways

  • The conductive plastic compounds market is expected to grow two-fold by 2031-end
  • Increased application in building & construction will spur sales
  • In terms of end-use, electric & electrical segment will witness substantial growth for the sale of conductive plastic compounds
  • Carbon nanotubes based fillers are expected to witness high demand backed by extensive usage in electric & electrical industry
  • China is expected to hold the largest market share owing to the surging demand of conductive plastic compounds in electric as well as automotive sector
  • UK and Germany will witness sluggish growth due to the stringent policies for the use of non-biodegradable plastics
  • Steady rise in demand due to increased application in automotive industry will spur the sales of conductive plastic compounds across the U.S.

Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6324

Competitive Landscape        

Product innovation, expansion of product portfolios, strategic partnerships & collaborations with top companies are some of the strategies prominent players rely on to expand their regional as well as global footprints in the industry.

For instance, Novation Solutions LLC, a materials science company that specializes in high-silicone dispersions, in January 2021, announced the launch of PURmix high-consistency rubber (HCR), healthcare plastic compound that enhances electrical properties of silicone rubber, using patent-pending technologies that incorporate a revolutionary single-wall carbon nanotube developed by Zeon Corporation.

In June 2020, Clariant Plastics & Coatings Healthcare Polymer Solutions announced the launch of static-reducing functional plastic compounds, which are able to increase dose reliability when used in drug delivery devices. The plastic compounds are part of the wider medical grade and includes polymers from PE to PEEK.

On March 16th 2021, Green Mantra Technologies, a global innovation leader that utilizes its advanced recycling technology to create unique specialty polymers and plastic compounds from discarded plastics, announced the partnership with HARKE Group, a leading distributor of specialty chemicals in Europe. Through this partnership, the companies aim to expand their customer base on the back of its sustainable solutions.

The compound houttuynia landscape appears to be highly consolidated, characterized by the presence of a majority of Chinese manufacturers. Offering new products remains the primary strategy of key market players.
Get More Insights-https://www.biospace.com/article/compound-houttuyina-market-surging-at-7-percent-cagr-increasing-application-in-natural-medicines-spurring-growth-170-pages-market-research-survey-by-fact-mr-a-market-research-and-competitive-intelligence-provider-/
More Insights Available

Fact.MR, in its new offering, presents an unbiased analysis of the compound houttuynia market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of type (tablets, mixture, capsules, and others) and distribution channel (hospital pharmacies, retail pharmacies, and online pharmacies), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa).

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/compound-houttuynia-market
Press Release: https://www.factmr.com/media-release/2011/global-compound-houttuynia-market

Categories
Pharmaceutical

Nizatidine Market is Projected to Expand at more than 9% CAGR over the Forecast Period 2021 to 2031

Award-winning consulting firm Fact.MR’s recently published report on the global demand of nizatidine market for the forecast period 2021-2031 expects an optimistic future outlook, projecting noteworthy growth for the said period. Growth is expected to be primarily fueled by extensive application in gastric disorder treatment.

According to a study published by a group of researchers at the University of Gothenburg, nearly 40% of adults suffer from a functional gastrointestinal disorder in a 73,000 person, 33 country survey. Functional gastrointestinal disorders represent a series of chronic disorders in the gastrointestinal tract that often include severe symptoms such as heartburn, acid reflux, and dyspepsia in the upper gastrointestinal tract.

Request a report sample to gain comprehensive insights at:
https://www.factmr.com/connectus/sample?flag=S&rep_id=6217

The market experienced hiccups in the recent past amid a series of product recalls by prominent manufacturers due to several compliance incompatibilities. However, these withdrawals have been overturned, reopening growth frontiers. For instance, in September 2020, Amneal Pharmaceuticals Inc. announced that its nizatidine oral solution 15 mg/ml was available for reorder across the U.S., meeting all FDA requirements.

Key Takeaways from Market Study
  • By type, nizatidine capsules of doses of 150 mg and 300 mg to remain most preferred
  • Retail and online sales of nizatidine products to experience massive incline over coming years
  • Resumption of regulatory approval grants to stimulate nizatidine sales across the U.S.
  • India to attract significant investments, attributed to high domestic manufacturing capabilities of generic drugs
  • China to generate high demand amid rising prevalence of gastric cancer and irritable bowel syndrome
nizatidine market
“Surging healthcare costs associated with availing high-grade gastrointestinal disorder treatment are prompting a shift towards consuming orally administered nizatidine capsules and tablets, ”says a Fact.MR analyst
Request Methodology & Get a Glimpse of Our Expertise
https://www.factmr.com/connectus/sample?flag=RM&rep_id=6217
Competitive Landscape

Major players in the market that are associated with offering nizatidine-based formulations and nizatidine, in itself, include Flynn Pharma, MedChemExpress, Mylan N.V., Glenmark Pharmaceuticals, Weightech (Hunan) Pharmaceutical, Hengdian Group, Dr. Reddy’s Laboratories, Eli Lily and Company, and Strides Pharma Science Limited.

These aforementioned players largely concentrate on offering different formulations of nizatidine so as to especially cater to gastrointestinal ailments. A majority of these players are scrambling to acquire regulatory approvals from appropriate authorities to secure a firm footing in the market across regions and increased their revenue and profit margins.

Key Takeaways

  • National Centre for Biotechnology Information (NCBI) states that China exhibits high incidence of irritable bowel syndrome (IBS), which affects 4-7% of the population. These figures point towards an increasing scope for the need of nizatidine drugs.
  • Increasing focus on health and wellness and resultantly rising healthcare spending is creating growth prospects within the U.S.
  • According to reports by India Brand Equity Foundation (IBEF), India is the largest global supplier of generic drugs. Hence, the market is expected to surge by 9%, showing greater expansion prospects.
  • Sales of nizatidine capsules are expected to surge at over 10% CAGR over the forecast period
Get More Insights- https://www.biospace.com/article/rising-cases-of-gastrointestinal-disorders-are-driving-the-nizatidine-market-fact-mr/
More Insights on the Nizatidine Market

Fact.MR, in its new offering, presents an unbiased analysis of the nizatidine treatment market, presenting historical demand data (2016-2020) and forecast statistics for the period of 2021-2031. The study divulges essential insights on the market on the basis of type (capsules, tablets, and others) and application (hospital pharmacies, retail pharmacies, and online pharmacies) across five major regions of the world (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The report provides qualitative and quantitative information on various players in this market. This report also tracks the market by both, supply side and demand side trends.

Explore Fact.MR’s Coverage on the Healthcare Domain

Genetic Testing Services Market – The future expansion of genetic testing services is heavily reliant on the advancement of information technology. Throughout the projected period, North America is expected to dominate the worldwide genetic testing services market. Increased demand for genetic testing to determine ancestry, as well as an increase in demand for in-vitro fertilization (IVF) and pre-implantation testing, are some of the primary reasons boosting market share. According to projections, the North American genetic testing market will account for over two-fifths of the total.

Rheumatoid Arthritis Stem Cell Therapy Market – Over the forecast period, the global market for rheumatoid arthritis treatments is expected to rise moderately. Over the projected period, the allogeneic mesenchymal stem cell segment is expected to lead the global rheumatoid arthritis stem cell therapy market. As the most accessible channel, hospitals are likely to account for a sizable portion of the global rheumatoid arthritis stem cell therapy market.

Serological Transplant Diagnostics Market – Serological transplant diagnosis, which is a critical component of successful and efficient organ transplantation, has grown rapidly in recent years. Growth in important distribution channels, such as hospitals and organ transplantation centres, to name a few, has boosted demand during the last five years, from 2016 to 2020, attracting more stakeholders to the business. Serological transplant diagnostic equipment sales are being fueled by an increase in incidence of serious lung, liver, and kidney disorders, as well as medical and diagnostic developments.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com
Research Insight: https://www.factmr.com/report/nizatidine-market
Press Release: https://www.factmr.com/media-release/2003/global-nizatidine-market 

Categories
Pharmaceutical

Demand for Plastic Blood Collection Tubes for Liquid Biopsy Is Poised to See a Healthy Growth Outlook at 6% CAGR During 2019 – 2029

Surpassing revenues worth US$ 215 Mn in 2019, sales of blood collection tubes for liquid biopsy are poised to see a healthy growth outlook at 6% CAGR during 2019 – 2029. Despite being an essential diagnostic product in the practice of laboratory biopsy testing, the blood collection tubes for liquid biopsy market is still young, and the application scope remains majorly limited to research industry.

High product availability is limited to developed regions such as North America, Europe, and Oceania. However, increased application of blood collection tubes for liquid biopsy in genetic diagnostics and other common diagnostic procedures is likely to bolster demand for blood collection tubes for liquid biopsy in following years.

The healthcare industry is consistently witnessing an increase in the number of biopsy procedures every year, globally, due to the increasing prevalence of cancer. Growing awareness and rise in cancer screening procedures has led to the growth of the blood collection tubes for liquid biopsy market which in turn has increased the rate of early diagnosis of cancer.

For More Insights Into The Market, Request a Sample of this Report –
https://www.factmr.com/connectus/sample?flag=S&rep_id=4495

Key Segments of the Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s study on the blood collection tubes for liquid biopsy market offers information divided into four important segments-product, application, end user, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Products
  • Plastic
  • Glass
Application
  • IVD
  • Research Use
End User
  • Healthcare Centers
  • R&D Centers
  • Diagnostic Centers
Region
  • North America
  • Latin America
  • Europe
  • East Asia
  • South Asia
  • Oceania
  • Middle East and Africa (MEA)

Access Research Methodology Prepared By Experts –
https://www.factmr.com/connectus/sample?flag=AE&rep_id=4495

Key Takeaways – Blood Collection Tubes for Liquid Biopsy

  • Healthcare centers would show remarkable growth in adoption of blood collection tubes for liquid biopsy owing to the rise in number of research activities.
  • Increasing prevalence of cancers will remain one of the major factors responsible for the growth of the blood collection tubes for liquid biopsy market.
  • Blood collection tubes for liquid biopsy market is a fragmented landscape.
  • Growing demand for single needle penetration for multiple tests is identified as the key growth engine, pushing adoption of blood collection tubes for liquid biopsy.

Key Players

  • Roche
  • Streck
  • Preanalytix
  • Norgen Biotek
  • Biocept

blood collection tubes for liquid biopsy market 02

Plastic Tubes Remain Highly Sought-after

On back of higher safety standards, plastic blood collection tubes for liquid biopsy will continue to gather preference over their glass counterparts. The former remains preferred for their greater reliability during routine clinical chemistry analysis, tumor screening, biopsy tests and chemotherapeutic drug monitoring. The shatter-resistant plastic further reduces the risk of exposure to pathogens and contamination.

Attractiveness of Asian Markets Intact

Growth opportunities for the blood collection tubes for liquid biopsy market players is picking up the pace in the East and South Asian regions. Increasing availability of economically affordable blood collection tubes would also be a significant booster to market growth. A large number of local manufacturers, particularly in China, Japan, and India, are increasing the scope for manufacturers and boosting the blood collection tubes for liquid biopsy market growth.

Full Access of this Report Is Available at
https://www.factmr.com/checkout/4495

Know More About Blood Collection Tubes for Liquid Biopsy Market

Fact.MR’s business intelligence also underlines groundbreaking insights into the competitive scenario of the blood collection tubes for liquid biopsy market, along with highlights of manufacturers’ differential strategies. The blood collection tubes for liquid biopsy market is majorly covered by the players offering conventional blood collection tubes for liquid biopsy. The key players’ operating in the blood collection tubes for liquid biopsy market will continue to focus on delivering of their products through direct sales and distribution channels.

Key Questions Answered in Fact.MR’s Blood Collection Tubes for Liquid Biopsy Market Report

  • Which regions will continue to remain the most profitable for blood collection tubes for liquid biopsy market players?
  • Which factors will induce a change in the demand for blood collection tubes for liquid biopsy during the assessment period?
  • How will the changing trends impact the blood collection tubes for liquid biopsy market?
  • How will the market players capture the untapped market opportunities in the blood collection tubes for liquid biopsy market?
  • How local players’ products will impact the adoption of blood collection tubes for liquid biopsy?

For More Insights 
https://www.biospace.com/article/bell-s-palsy-treatment-demand-propelled-by-growing-prevalence-of-bell-s-palsy-says-fact-mr

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for Home-based Behavioural Health Treatment Services Is Estimated CAGR of 2.4% Over the Assessment Period

Big data and analytics will drive patient outcomes in a big way, and the coming years will witness a growing emphasis on healthcare service providers in the business of gathering and processing patient health data. Creating outcome-oriented financial models to maximize reimbursements in value-based healthcare will be a strategic shift from the traditional fees-for-services model. This implies that pharmaceutical companies will need to devise appropriate measures to optimize costs and improve the quality of patient care.

Burden of mental illness on Europe’s economy is among the largest in the world, inadvertently making it the most lucrative region for players in the behavioural health treatment market, with the region slated to account for a staggering 47% of the global market by 2027. Total cost associated with mental health treatment amounted to around US$ 668 Bn in 2018 across the EU, translating to 4% of the GDP of Europe. Taking cue from this opportunity, key players are striving to expand their treatment facilities to offer easy accessibility to patients.

For More Insights Into The Market, Request a Sample of this Report –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

However, uneven distribution of therapy facilities and rehabilitation centres in rural regions across the globe is projected to result in sluggish growth of the behavioural health treatment market, with an estimated CAGR of 2.4% during the forecast period (2020-2027).

A senior analyst at Fact.MR opines,“Advent of on-demand service model will remain crucial for the behavioural health treatment market, especially in developing regions, on account of high social stigma related to opting for mental health therapy. Additionally, value-based subscription models offered by on-demand counselling would be easy on the pockets of patients, which is projected to drive a massive shift from hospital and outpatient-based care to home-based care.”

Key Takeaways of Behavioural Health Treatment Market Study

  • According to WHO, 800,000 suicides are recorded every year, on the back of depression and anxiety disorders. Symptoms of depression are found to be high among millennial cohort as compared to other age groups, influenced by reckless use of social media and stressful lifestyles. Revenue generation through patient base suffering from depression is projected to grow by 3.2% in 2027 over 2026.
  • Individuals will continue to show a high interest in outpatient counselling services, as these programs offer freedom of movement over inpatient hospital treatment services. Given the high relevance of this influence, outpatient counselling services are projected to witness a marginal rise, at a CAGR of around 2.7% during the forecast period.
  • Social stigma associated with mental health discourages individuals from seeking proper treatment and counselling, which could hinder behavioural health treatment market growth during the forecast period.
  • Asia Pacific is projected to record the highest growth rate of nearly 2.8% during 2020-2027, which is attributable to increase in service centres and debunking of mental health taboos through awareness campaigns by various government and non-governmental organizations.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=S&rep_id=4370

Behavioural Health Treatment Market – Assessment of Key Segments

Disorder
  • Depression
  • Anxiety
  • Schizophrenia
  • Bipolar Disorder
  • Alcohol Use Disorders
  • Substance Use Disorders
  • Eating Disorders
  • Post-traumatic Stress Disorders
  • Others
Service
  • Inpatient Hospital Treatment Services
  • Outpatient Counselling
  • Emergency Mental Health Services
  • Home-based Treatment Services
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Full Access of this Report Is Available At

https://www.factmr.com/checkout/4370

market share estimation of key regions in behavioural health treatment market

Key Players Listed in this Comprehensive Report on the Behavioural Health Treatment Market Include

Although the behavioural health treatment market boasts of a number of organized players, numerous individual practitioners operating at regional and local levels generate a significant chunk of revenue. Lack of stringent regulations for practicing behavioural health services reduces the entry barrier in the market, and further adds a layer of fragmentation to the behavioural health treatment market.

Key focus of players to strengthen their foothold in the behavioural health treatment market remains on the expansion of inpatient care facilities. For instance, in January 2019, Acadia Healthcare announced the acquisition of Whittier Pavilion, which is an inpatient psychiatric facility with 71 beds. In May 2019, MercyOne Central Iowa and Universal Health Services, Inc. established a new facility at Iowa, with 100 beds, to offer high quality services for behavioural health.

  • Promises Behavioural Health
  • Pyramid Healthcare
  • Acadia Healthcare
  • Ascension Seton
  • CareTech Holdings PLC
  • STRATEGIC BEHAVIOURAL HEALTH
  • The MENTOR Network
  • North Range Behavioural Health
  • Universal Health Services Inc.
  • Behavioural Health Network Inc.

For More Insights https://www.biospace.com/article/bone-marrow-processing-systems-growth-driven-by-progressions-in-bone-marrow-needles-and-harvest-technology-says-fact-mr/

Find More Valuable Insights on Behavioural Health Treatment Market

Fact.MR, in its new offering, brings to the fore an unbiased analysis of the global behavioural health treatment market, presenting historical demand data (2017-2019), and forecast statistics for the period 2020-2027. The study divulges compelling insights on the behavioural health treatment market on the basis of disorder (depression, anxiety, schizophrenia, bipolar disorder, alcohol use disorders, substance use disorders, eating disorders, post-traumatic stress disorders (PSTD), and others), service (inpatient hospital treatment services, outpatient counselling, emergency mental health services, home-based treatment services, and others), across five major regions.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

Demand for NGS-Based Predictive Diagnostics Is Expected to Remain Significantly High In North America : Fact.MR

Mass technological transformation of the global healthcare industry has left key market participants struggling to traverse the complexities of medical and life sciences. Given the shifting dynamics of the global healthcare sector, pharma and biotech companies are taking measured efforts to improve patient outcomes in an effective manner, while keeping a careful watch on the bottom line.

For the area of medical diagnosis, accuracy and precision are inevitable. This has triggered healthcare companies to resort to predictive diagnostic tools that can amplify the precision as well as reliability of diagnostics, and help healthcare providers to improve their patient care and medical outcomes.

The global sales of predictive diagnostics are expected to reach the valuation of over US$ 3 billion by 2031, finds a recent study published by Fact.MR. The study opines that the convergence of healthcare practices and next-generation technologies will take an upsurge in the coming years, and this will make predictive diagnostics the ‘New Normal’ in the healthcare industry in the coming future.

Predictive diagnostics is one of the most prominent applications of Artificial Intelligence and advanced data technologies in the healthcare domain. Predictive diagnostics also play an important role in identifying the patients’ reaction to different treatments, which can ultimately help healthcare providers to dramatically improve medical outcomes. Constant advancements in the technologies will further strengthen the demand for predictive diagnostics, reiterating the positive growth potential for stakeholders in the market, opines the Fact.MR study.

For More Insights Into The Market, Request a Sample of this Report –

https://www.factmr.com/connectus/sample?flag=S&rep_id=5509

“Personalized treatments and precision medicines are among the top, fast-growing trends in the healthcare industry, and these are the salient factors that are contributing to the growth of the predictive diagnostics market. Doctors, physicians, pathologists among all the other healthcare service providers are making a move towards diagnostic tools that can offer maximum reliability to incur positive medical outcomes at a lower cost. This fortifies the role of technology and innovation in the predictive diagnostics market. In the coming years, Manufacturers in the predictive diagnostics market must benefit from this trend by increasing awareness in the healthcare domains of developing economies,” says a lead analyst at Fact.MR.

Key Takeaways

  • Growing adoption of advanced technologies in the healthcare industry indicates the potential for growth in the predictive diagnostics market. By 2031, the global market for predictive diagnostics is expected to surpass the valuation of US$ 3 billion, creating new opportunities for diagnostic tools with high accuracy and precision in the coming decade.
  • The predictive diagnostics market is expected to grow at a CAGR of around 10% between 2021 and 2031. Manufacturers are expected to innovate around the adoption of technologies to predict the risks of various diseases such as cancer, neurological disorders, etc.
  • Based on test types, the adoption of predictive diagnostics based on polymerase chain reaction (PCR) tests is expected to remain high, which manufacturers are slowly moving towards next-generation sequencing (NGS) platforms by integrating advanced technologies in their tools.
  • With the growing demand for predictive diagnostic tools for identifying the risks of various types of cancer, manufacturers in the predictive diagnostics market are upscaling the production and research & development effort to discover accurate predictive tests for cancer.
  • The demand for predictive diagnostics is expected to remain significantly high in developed regions, especially in North America. Growing presence of market leaders and increasing healthcare spending in the United States makes the region a profitable market for manufacturers and other stakeholders.

Access Research Methodology Prepared By Experts –

https://www.factmr.com/connectus/sample?flag=RM&rep_id=5509

predictive diagnostics market regional analysis by FactMR

Key Players

Key players in the global predictive diagnostics market are Abbott Laboratories, Therawis, F.Hoffmann-La Roche Ltd., BIOMÉRIEUX SA, Agilent Technologies, Illumina, Inc., Thermo Fisher Scientific, Inc., Bio-Rad, Myriad Genetics, Inc., Genesis Genetics, Centogene N.V., BGI, 23andMe, Inc., Predictive Oncology, Counsyl, Inc., Bio-Rad Laboratories Inc., Mylab Discovery Solutions Pvt. Ltd., and ARUP Laboratories.

Predictive Diagnostics for Breast and Ovarian Cancer – A Key Trend

The incidence of genetically transferred cancer types such as breast cancer and ovarian cancer has increased dramatically in the past few years. According to the World Cancer Research Fund, over 2 million new cases of breast cancer and more than 300,000 new cases of ovarian cancer were recorded across the world in 2018.

Also, cancer is one of the leading causes of death, which makes it important for healthcare providers to use high-tech predictive diagnostics to identify risks of cancer in individuals. This is one of the key factors that are likely to trigger this trend in the predictive diagnostics market.

Full Access of this Report Is Available At

https://www.factmr.com/checkout/5509

More Valuable Insights on the Predictive Diagnostics Market

The recent study published by Fact.MR provides detailed insights into how the global market for predictive diagnostics is likely to develop during the period of 2021 to 2031. The report also offers actionable insights for manufacturers and other stakeholders to devise appropriate strategies to win in the global predictive diagnostics market in the coming years.

Fact.MR’s report categorizes the insights on the predictive diagnostics market based on tests (PCR based and NSG (Sequencing) based), indication (cancer, metabolic disorders, neurological disorders, musculoskeletal disorders, and others), end users (diagnostics, genetic laboratories and clinics, and research and academic institutes) and seven regions (North America, Latin America, Europe, East Asia, South Asia, Oceania, and Middle East & Africa).

Key Questions Answered

  • Predictive diagnostics for which indications will witness high adoption across the world?
  • What are the key challenges encountered by the new entrants in the global predictive diagnostics market?
  • Which factors may hinder the growth of the global predictive diagnostics market in the coming decade?
  • What are the upcoming trends in the predictive diagnostics market that redefine its growth?
  • Which strategies will help manufacturers to consolidate a strong position in the market for predictive diagnostics in North America?

For More Insights

https://www.biospace.com/article/emergence-of-new-age-testing-facilities-and-methods-are-playing-key-role-in-increased-uptake-of-carbapenem-resistant-enterobacteriaceae-testing-market-notes-fact-mr/

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:

US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Visit Our Website: https://www.factmr.com
Categories
Pharmaceutical

North America Dominates Nano Healthcare Technology for Active Implantable Devices Over the Assessment Period

Increasing demand for advanced and effective equipment and favorable government initiatives are expected to drive the nano healthcare technology market, finds Fact.MR in a new study. The increasing geriatric population along with developments in the healthcare sector are key drivers of the market. Increasing government initiatives and investments are primary factors that are encouraging the adoption of nanotechnology in healthcare.

The advent of nano technology has helped in enhancing and improving various healthcare systems and is creating opportunities to transform various processes within the healthcare industry, including diagnosis, treatment, drug delivery, and others. Incorporating nano technology in monitoring devices, imaging, and bioassay ensures improved accuracy in disease diagnosis.

There has been increasing adoption of nano technology in the treatment of chronic diseases. It finds application in biochips, implantable materials and medical textile, and wound dressing. The growing number of patients affected by COVID-19 also has affected the market growth.

Request a report sample to gain comprehensive market insights at

https://www.factmr.com/connectus/sample?flag=S&rep_id=5430

Key Takeaways from Nano Healthcare Technology Market Report

  • There has been an increase in adoption of biochips to improve disease diagnosis, which is aiding the sales uptick in nano healthcare technology market.
  • High costs and complex product approval procedures however might restrict demand to a certain extent
  • North America will emerge as a dominant market as the region exhibits high investment in modern healthcare. Asia Pacific too will offer lucrative growth opportunities through the forecast period
  • The demand for active implantable devices is poised to surge exponentially in the coming years, creating attractive opportunities for growth
  • In the coming years, therapeutic application of nano healthcare technology will rise significantly, finds Fact MR in a study

“Demand for advanced treatment processes will continue rising as the healthcare sector witnesses a surge in incidence of chronic ailments. Technological improvements are highly sought-after, now more than ever before, especially as countries around the world try containing the spread of the novel coronavirus. Nano-technology is believed to have potential for enabling early detection of COVIDF-19 even before a patient starts showing symptoms. In the coming years, its penetration across the healthcare sector is likely to surge considerably,” said a lead analyst at Fact MR.

Speak to Research Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=5430

COVID-19 Impact on Nano Healthcare Technology Market

The COVID-19 pandemic has disrupted several industries including the nano healthcare technology market. The implementation of lockdown and transport bans have affected the production of equipment. But the increasing number of patients has positively affected demand for nano technology based devices.

The market is expected to recover from the pandemic at a moderate growth rate. Increasing caution regarding health is expected to increase the use of nano technology based devices in the healthcare industry.

Competitive Landscape of Nano Healthcare Technology Market

Players operating in the market are now focusing on the research and development of nano technology to improve its efficiency across diverse applications. Developments underway to improve drug delivery and ensure better accuracy in diagnosis.

Nano Technology is now being used to develop smart pills that will increase treatment efficiency. Special nano bots are also being introduced to assist and conduct various surgeries. There have been major concerns regarding the side effects and deficiencies of using nano technology due to the less research conducted. Players are focusing on dispelling these doubts by increasing experimentation and research.

For instance, researchers at Massachusetts Institute of Technology, Draper, and Brigham and Women’s Hospital have unveiled the design of an ingestible capsule that can be controlled using wireless technology – Bluetooth. The design of this capsule can be customized to sense environmental conditions, deliver drugs, and live in stomach for nearly a month, transmitting information to users and responding to instructions they share via smartphones.

Full Access of this Report Is Available at

https://www.factmr.com/checkout/5430

Some of the key players in the nano healthcare technology market are

3M Company
Thermo Fisher Scientific Inc.
Smith & Nephew Plc.
GE Global Research
Greiner Bio One International GmbH
Dentsply Sirona
Ferro Corporation
Boston Scientific Corporation
Sonova
LivaNova Plc.
Abbott Laboratories
Stryker Corporation
Merck KGaA
Demant A/S
Eppendorf AG
Medtronic
Cochlear Ltd.

For More Insights https://www.biospace.com/article/canine-influenza-treatment-demand-driven-by-high-unmet-requirement-for-treatment-of-canine-flu-says-fact-mr

Key Questions Answered in Fact.MR’s Nano Healthcare Technology Market Report

  • Which regions will continue to remain the most profitable regional markets for nano healthcare technology market players?
  • Which factors will induce a change in the demand for nano healthcare technology during the assessment period?
  • How will changing trends impact the nano healthcare technology market?
  • How can market players capture the low-hanging opportunities in the nano healthcare technology market in developed regions?
  • Which companies are leading the nano healthcare technology market?
  • What are the winning strategies of stakeholders in the nano healthcare technology market to upscale their position in this landscape?

Valuable Insights into Nano Healthcare Technology Market Report

In its latest report, Fact.MR has presented a detailed analysis of the nano healthcare technology market along with an assessment for the years 2020-2030. In order to provide a better understanding, the market has been divided into several segments.

The market has been segmented based on the product into biochips, implantable materials, medical textile & wound dressing, active implantable devices and others. On the basis of application, the market has been divided into therapeutic applications, diagnostic applications and research applications. The market is segmented based on geography into North America, Latin America, Europe, East Asia, South Asia, Oceania and Middle East & Africa.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Cables and Leads for Medical Devices Market Sustains Competitiveness by Adoption of Technological Innovations

Rising need for medical equipment and devices due to surge in patients following the COVID-19 pandemic has increased demand for cables and leads for medical equipment, finds Fact.MR. Cables and leads are key elements in medical equipment that is used in laboratories, operating rooms, and monitoring systems.

Increasing cases of cardiovascular diseases has caused growth in usage of ECG equipment and accessories, fuelling demand for cables and leads. With rising concerns regarding infection control and transmission, medical centers are opting to use disposable medical equipment, increasing demand for cables and leads for medical equipment in the healthcare industry.

The global cables and leads for medical equipment market is projected to rise at a steady CAGR of around 5% through 2030.

“With rising hospital admission cases amidst the COVID-19 pandemic, the need for medical devices has surged, thereby lending impetus to the growth of the cables and leads for medical equipment market,”says a Fact.MR analyst.

Request a report sample to gain comprehensive market insights at https://www.factmr.com/connectus/sample?flag=S&rep_id=5418

Key Segments in Cables and Leads for Medical Equipment Industry Research

  • Product

    • Cables
    • Leads

  • Application

    • Pacemakers
    • Defibrillators
    • EEG
    • ECG

  • End User

    • Cables and Leads for Medical Equipment at Hospitals
    • Cables and Leads for Medical Equipment at Ambulatory Care Centers
    • Cables and Leads for Medical Equipment at Academic Research Institutes
    • Cables and Leads for Medical Equipment at Specialty Clinics

Speak to Research Analyst

https://www.factmr.com/connectus/sample?flag=AE&rep_id=5418

Key Takeaways from Cables and Leads for Medical Equipment Market Report

  • The use of cables and wires in single-use or disposable medical equipment has increased due to their ability to reduce cross-contamination and limit risk of harmful pathogens.
  • While there has been increasing adoption of disposable ECG lead sets and cables, high price is a major hindrance for this segment.
  • Australia, India, and South Korea are predicted to be key cables and leads for medical equipment markets in the Asia Pacific region.
  • The implementation of lockdowns and transport bans due to the COVID-19 pandemic has caused disruptions in all sectors, including the cables and leads for medical equipment market. Lack of raw materials has caused a slowdown in the production of medical equipment.
  • Though there has been a lull in production, demand for cables and leads for medical equipment has increased due to rising number of patients in hospitals. Increasing need for monitoring devices and medical equipment in hospitals has contributed to display larger than expected growth across the world.

nano healthcare technology market regional analysis

Research & Development Efforts to Boost Growth

Players are now focusing on developing and creating cables and leads for medical equipment that are user-friendly and cost-efficient. They are using efforts to research & develop infection preventing technical solutions. Increasing demand for disposable lead wires and cables has created more opportunities for players, which had led to the emergence of new manufacturers in the cables and leads for medical equipment market space.

Rising environmental concerns have increased focus on the creation of ecofriendly cables and leads for medical equipment. Nikomed USA recently introduced BioWire, a non-metallic disposable and universal lead wire system that is recyclable. These leads produced are easily disposable and can be incinerated without the need for extra processing or preparation. Increasing amount of players are now focused on providing products with better efficiency and lower risk rates.

Full Access of this Report Is Available at

https://www.factmr.com/checkout/5418

Some of the key players in the cables and leads for medical equipment market are

  • 3M Company
  • Curbell Medical Products Inc.
  • Schiller Americas Inc.
  • Boston Scientific Corporation
  • Spacelabs Healthcare Inc.
  • Koninklijke Philips N.V.
  • Medtronic Plc.
  • ConMed Corporation
  • LivaNova Plc.
  • Abbott Laboratories.

Key Questions Answered in Report

  • Which are the most lucrative cables and leads for medical equipment market?
  • Which factors will impact the growth of the market?
  • How will changing trends impact the strategies of market players?
  • How can market players capture the low-hanging opportunities across regions?
  • Which companies are leading the cables and leads for medical equipment market?
  • What are the winning strategies of stakeholders in the market?

Get More Insights of Fact.MR –

https://www.biospace.com/article/constant-technological-developments-and-increasing-r-and-d-efforts-are-pushing-to-newer-heights-finds-fact-mr/

Valuable Insights on Cables and Leads for Medical Equipment Market Report

Fact.MR, in its latest report, has presented detailed analysis on the cables and leads for medical equipment market with the inclusion of an assessment for the years 2020 to 2030. In order to provide precise analysis, the cables and leads for medical equipment market has been divided into various segments. The market is segmented based on product into cables and leads.

The market is divided on the basis of application into pacemakers, defibrillators, EEG, and ECG. Based on end user, the cables and leads for medical equipment market is divided into hospitals, ambulatory care centers, academic research institutes, specialty clinics, and others. On the basis of geography, the market is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania, and the Middle East & Africa.

About Fact.MR

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. We have offices in the US and Dublin, whereas our global headquarter is in Dubai. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have in our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
E: sales@factmr.com
Website: https://www.factmr.com

Categories
Pharmaceutical

Blood Borne Testing Market to Witness a Tremendous Growth Due to COVID-19 Pandemic – Exclusive Report by Fact.MR

Fact.MR: Rising incidence of bacterial infections has fueled the need for blood borne testing for early diagnosis of potential illness and ensuring timely treatment. Emergence of lethal pathogens such as Ebola, Dengue, Zika, and West Nile Virus is creating a pressing need for technologically advanced blood borne testing systems.

This Market Research Survey highlights the key reasons behind increasing demand of Blood Borne Testing. These factors have translated into high adoption of point of care devices, subsequently propelling sales of blood borne testing. As efforts to contain the spread of these infections continue to grow, the global blood borne testing market is projected to expand simultaneously at over 7-8% CAGR between 2021 and 2031, finds Fact.MR in a recent market analysis.

In 2020, as the COVID-19 pandemic shook the world, opportunities for development of at-home rapid tests were also created. With restrictions in movement, at-home rapid tests were widely preferred, acting instrumentally in the containment of novel coronavirus.

Request a report sample to gain comprehensive insights at:

https://www.factmr.com/connectus/sample?flag=S&rep_id=6460

Additionally, rapid increase in the incidence of severe infections including HIV, HBV, and Hepatitis C will spur sales of blood borne testing systems. Early detection of HIV using point-of-care testing systems will result in better monitoring of disease progression and streamlined patient management.

Government-backed technological advancements in blood borne testing devices are creating the need for efficient testing kits, including ELISA and rapid tests, which in turn is augmenting the global blood borne testing market growth.

High adoption of advanced digital technology in healthcare will lead to the expansion of blood borne testing market in the U.S. In addition, supportive government policies and robust healthcare infrastructure will propel the growth of blood borne testing market through 2031. 

Key Segments

By Test Type

  • Immunoassay
  • ELISA
  • Rapid Test

By Modal

  • Benchtop
  • Portable

By End User

  • Hospital
  • Clinics
  • At home
  • Others

Competitive Landscape

Key players operating in the blood borne testing market are aiming at innovations in products and new product launches as a part of their growth strategies to establish a strong footprint in the global market. For instance:

In March 2020, CTK Biotech Inc. launched 2 testing kits for actively detecting the novel coronavirus. The tests included a real-time PCR-based nucleic acid detection kit and a serological rapid screening test.

In October 2020, EKF Diagnostics announced the launch of new testing kits for secure collection, handling, and transportation of pathogenic samples, including influenza and COVID-19. These kits are available in postal sample kits for at-home use and multi-pack of sample kits for on-site mass sampling.

Request for Blood Borne Testing Market Customization at: https://www.factmr.com/connectus/sample?flag=RC&rep_id=6460

Top Distributors of Blood Borne Testing Include:

  • CTK Biotech Inc.
  • Biochrome Scientific.
  • Intec
  • Coris BioConcept
  • Athenese Dx
  • EKF Diagnostics
  • Ads Biotec Inc.
  • Abingdon Health

Key Takeaways from Blood Borne testing Market Analysis

  • Sales of rapid tests are anticipated to gain traction owing to factors including need for early detection of possible infection to contain rising cases of COVID-19.
  • Based on end-users, at-home blood borne testing will continue gaining momentum.
  • Demand for blood borne portable testing models will increase owing to rapid increase in adoption of point-of-care devices.
  • The U.S. is forecast to dominate the blood borne testing market due to high presence of leading players and early adoption of digital healthcare technologies.
  • The U.K. will emerge as a lucrative market with increasing number of government-back research and development undertaken in the country’s healthcare sector.

Read More Trending and Similar Reports from Fact.MR – https://www.biospace.com/article/growing-requirement-of-research-activities-to-fuel-demand-for-chromatography-syringes-market-states-fact-mr/

Explore Fact.MR’s Coverage on the Biospace Domain

Arrhythmogenic Right Ventricular Dysplasia Treatment Market: A recent study by Fact.MR on arrhythmogenic right ventricular dysplasia treatment market offers indepth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

Hyperkalaemia Treatment Market: Fact. MR’s extensive coverage on hyperkalaemia treatment market offers in-depth insights about the prominent growth dynamics that are likely to aid expansion of growth prospects in the near future.

Atherosclerotic renovascular treatment Market: Fact.MR’s expansive Atherosclerotic renovascular treatment market report sheds light on the prominent dynamics expected to shape future growth.

About Us:

Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.

Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-158

Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: sales@factmr.com
Visit Our Website: https://www.factmr.com